These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15319770)

  • 1. Graft-versus-lymphoma effects: clinical review, policy proposals, and immunobiology.
    Grigg A; Ritchie D
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):579-90. PubMed ID: 15319770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
    Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M;
    J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation.
    Hoogendoorn M; Olde Wolbers J; Smit WM; Schaafsma MR; Jedema I; Barge RM; Willemze R; Falkenburg JH
    Clin Cancer Res; 2005 Jul; 11(14):5310-8. PubMed ID: 16033850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation.
    Pillai A; Teo P; George T; Mukhopadhyay A; Dejbakhsh-Jones S; Strober S
    Bone Marrow Transplant; 2007 Sep; 40(5):487-97. PubMed ID: 17603512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The graft-versus-lymphoma effect: clinical review and future opportunities.
    Butcher BW; Collins RH
    Bone Marrow Transplant; 2005 Jul; 36(1):1-17. PubMed ID: 15895112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.
    Bloor AJ; Thomson K; Chowdhry N; Verfuerth S; Ings SJ; Chakraverty R; Linch DC; Goldstone AH; Peggs KS; Mackinnon S
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):50-8. PubMed ID: 18158961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect.
    Hamadani M; Awan FT; Elder P; Lin TS; Porcu P; Blum KA; Devine SM
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):480-3. PubMed ID: 18342792
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation.
    Sangiolo D; Mesiano G; Carnevale-Schianca F; Piacibello W; Aglietta M; Cignetti A
    Expert Opin Biol Ther; 2009 Jul; 9(7):831-40. PubMed ID: 19463075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic transplantation in lymphoma: current status.
    Schmitz N; Dreger P; Glass B; Sureda A
    Haematologica; 2007 Nov; 92(11):1533-48. PubMed ID: 18024402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
    Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
    Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa immunoglobulin light chain polymorphisms and survival after allogeneic transplantation for B-cell malignancies: a potential graft-vs-leukaemia target.
    Etto TL; Stewart LA; Muirhead J; Bailey M; Schwarer AP
    Tissue Antigens; 2007 Jan; 69(1):56-61. PubMed ID: 17212708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A class II-restricted cytotoxic T-cell clone recognizes a human minor histocompatibility antigen with a restricted tissue distribution.
    Holloway PA; Kaldenhoven N; Kok-Schoemaker HM; Dijk Mv; Otten HG; Tilanus M; Postma S; Mutis T; Lokhorst HM; Bloem AC
    Br J Haematol; 2005 Jan; 128(1):73-81. PubMed ID: 15606552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathologist's view point. Part II --aggressive lymphomas.
    Pileri SA; Ascani S; Sabattini E; Fraternali-Orcioni G; Poggi S; Piccioli M; Piccaluga PP; Gamberi B; Zinzani PL; Leoncini L; Falini B
    Haematologica; 2000 Dec; 85(12):1308-21. PubMed ID: 11114138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens.
    Caraway NP; Gu J; Lin P; Romaguera JE; Glassman A; Katz R
    Cancer; 2005 Apr; 105(2):110-8. PubMed ID: 15712276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigen-specific allogeneic immunotherapy--selective augmentation of GVL effects].
    Akatsuka Y
    Gan To Kagaku Ryoho; 2008 May; 35(5):713-9. PubMed ID: 18487905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma.
    Mi JQ; Manches O; Wang J; Perron P; Weisbuch S; Marche PN; Renversez JC; Bensa JC; Sotto JJ; Cahn JY; Leroux D; Bonnefoix T
    Br J Haematol; 2006 Nov; 135(3):324-35. PubMed ID: 16984392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished expression of CD19 in B-cell lymphomas.
    Yang W; Agrawal N; Patel J; Edinger A; Osei E; Thut D; Powers J; Meyerson H
    Cytometry B Clin Cytom; 2005 Jan; 63(1):28-35. PubMed ID: 15624204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting beneficial alloreactive T cells.
    Barber LD; Madrigal JA
    Vox Sang; 2006 Jul; 91(1):20-7. PubMed ID: 16756597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.